11 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 34686650 | CPAP enhances and maintains chronic inflammation in hepatocytes to promote hepatocarcinogenesis. | 2021 Oct 22 | 2 |
2 | 34921636 | TM4SF5-mediated liver malignancy involves NK cell exhaustion-like phenotypes. | 2021 Dec 18 | 2 |
3 | 30474622 | The Adenosine Monophosphate (AMP) Analog, 5-Aminoimidazole-4-Carboxamide Ribonucleotide (AICAR) Inhibits Hepatosteatosis and Liver Tumorigenesis in a High-Fat Diet Murine Model Treated with Diethylnitrosamine (DEN). | 2018 Nov 26 | 1 |
4 | 27696512 | Melatonin prevents deregulation of the sphingosine kinase/sphingosine 1-phosphate signaling pathway in a mouse model of diethylnitrosamine-induced hepatocellular carcinoma. | 2017 Jan | 1 |
5 | 28401002 | Gpr110 deficiency decelerates carcinogen-induced hepatocarcinogenesis via activation of the IL-6/STAT3 pathway. | 2017 | 1 |
6 | 30873458 | Obesity and diabetes accelerate hepatocarcinogenesis via hepatocyte proliferation independent of NF-κB or Akt/mTORC1. | 2016 Apr 15 | 2 |
7 | 25519169 | C-terminal-truncated hepatitis B virus X protein enhances the development of diethylnitrosamine-induced hepatocellular carcinogenesis. | 2015 Mar | 1 |
8 | 22911886 | Serine 727 phosphorylation of STAT3: an early change in mouse hepatocarcinogenesis induced by neonatal treatment with diethylnitrosamine. | 2014 Jan | 4 |
9 | 24476004 | Loss of suppressors of cytokine signaling 3 promotes aggressiveness in hepatocellular carcinoma. | 2014 Aug | 2 |
10 | 21684247 | Hepatoprotective versus oncogenic functions of STAT3 in liver tumorigenesis. | 2011 Aug | 1 |
11 | 22136659 | STAT3 activation in monocytes accelerates liver cancer progression. | 2011 Dec 5 | 2 |